BACKGROUND: Accumulation of β-amyloid protein (Aβ) and tau protein is the main feature of Alzheimer disease neuropathogenesis. Anesthetic isoflurane, but not desflurane, may increase Aβ levels in vitro and in animals. Therefore, we set out to determine the effects of isoflurane and desflurane on cerebrospinal fluid (CSF) levels of Aβ and tau in humans. METHODS: The participants were assigned into spinal anesthesia (N=35), spinal plus desflurane anesthesia (N=33), or spinal plus isoflurane anesthesia (N=38) group by randomization using computer-generated lists. Pre- and postoperative human CSF samples were obtained through an inserted spinal catheter. The levels of Aβ (Aβ40 and Aβ42) and total tau in the CSF were determined. RESULTS: Here, we show that isoflurane, but not desflurane, was associated with an increase in human CSF Aβ40 levels (from 10.90 to 12.41 ng/ml) 24 h after the surgery under anesthesia compared to spinal anesthesia (from 11.59 to 11.08 ng/ml), P=0.022. Desflurane, but not isoflurane, was associated with a decrease in Aβ42 levels 2 h after the surgery under anesthesia (from 0.39 to 0.35 ng/ml) compared to spinal anesthesia (from 0.43 to 0.44 ng/ml), P=0.006. Isoflurane and desflurane did not significantly affect the tau levels in human CSF. CONCLUSIONS: These studies have established a system to study the effects of anesthetics on human biomarkers associated with Alzheimer disease and cognitive dysfunction. These findings have suggested that isoflurane and desflurane may have different effects on human CSF Aβ levels.
RCT Entities:
BACKGROUND: Accumulation of β-amyloid protein (Aβ) and tau protein is the main feature of Alzheimer disease neuropathogenesis. Anesthetic isoflurane, but not desflurane, may increase Aβ levels in vitro and in animals. Therefore, we set out to determine the effects of isoflurane and desflurane on cerebrospinal fluid (CSF) levels of Aβ and tau in humans. METHODS: The participants were assigned into spinal anesthesia (N=35), spinal plus desflurane anesthesia (N=33), or spinal plus isoflurane anesthesia (N=38) group by randomization using computer-generated lists. Pre- and postoperative human CSF samples were obtained through an inserted spinal catheter. The levels of Aβ (Aβ40 and Aβ42) and total tau in the CSF were determined. RESULTS: Here, we show that isoflurane, but not desflurane, was associated with an increase in human CSF Aβ40 levels (from 10.90 to 12.41 ng/ml) 24 h after the surgery under anesthesia compared to spinal anesthesia (from 11.59 to 11.08 ng/ml), P=0.022. Desflurane, but not isoflurane, was associated with a decrease in Aβ42 levels 2 h after the surgery under anesthesia (from 0.39 to 0.35 ng/ml) compared to spinal anesthesia (from 0.43 to 0.44 ng/ml), P=0.006. Isoflurane and desflurane did not significantly affect the tau levels in human CSF. CONCLUSIONS: These studies have established a system to study the effects of anesthetics on human biomarkers associated with Alzheimer disease and cognitive dysfunction. These findings have suggested that isoflurane and desflurane may have different effects on human CSF Aβ levels.
Authors: Junxia X Tang; Dimitry Baranov; Mary Hammond; Leslie M Shaw; Maryellen F Eckenhoff; Roderic G Eckenhoff Journal: Anesthesiology Date: 2011-10 Impact factor: 7.892
Authors: Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski Journal: Ann Neurol Date: 2009-04 Impact factor: 10.422
Authors: Michael S Avidan; Adam C Searleman; Martha Storandt; Kara Barnett; Andrea Vannucci; Leif Saager; Chengjie Xiong; Elizabeth A Grant; Dagmar Kaiser; John C Morris; Alex S Evers Journal: Anesthesiology Date: 2009-11 Impact factor: 7.892
Authors: E Bufill; A Bartés; A Moral; T Casadevall; M Codinachs; E Zapater; J Carles Rovira; P Roura; R Oliva; R Blesa Journal: Neurologia Date: 2009-03 Impact factor: 3.109
Authors: Carolina Quiroga; Rafael E Chaparro; Rachel Karlnoski; Diana Erasso; Marcia Gordon; David Morgan; Gerardo Bosco; Alessandro Rubini; Andrea Parmagnani; Antonio Paoli; Devanand Mangar; Enrico M Camporesi Journal: Neurotox Res Date: 2014-06-14 Impact factor: 3.911
Authors: Federico Bilotta; Elisabetta Stazi; Alexander Zlotnik; Shaun E Gruenbaum; Giovanni Rosa Journal: Curr Pharm Des Date: 2014 Impact factor: 3.116
Authors: Miles Berger; Jacob W Nadler; Allan Friedman; David L McDonagh; Ellen R Bennett; Mary Cooter; Wenjing Qi; Daniel T Laskowitz; Vikram Ponnusamy; Mark F Newman; Leslie M Shaw; David S Warner; Joseph P Mathew; Michael L James Journal: J Alzheimers Dis Date: 2016-04-15 Impact factor: 4.472
Authors: Andrew R Mayer; Andrew B Dodd; Josef M Ling; David D Stephenson; Julie G Rannou-Latella; Meghan S Vermillion; Carissa J Mehos; Victoria E Johnson; Andrew P Gigliotti; Rebecca J Dodd; Irshad H Chaudry; Timothy B Meier; Douglas H Smith; Denis E Bragin; Chen Lai; Chelsea L Wagner; Vivian A Guedes; Jessica M Gill; Rachel Kinsler Journal: Shock Date: 2021-04-01 Impact factor: 3.533